We are seeking a seasoned Clinical Operations Consultant to lead the execution of a Phase 1b/2a precision oncology clinical trial in solid tumors on a part-time / fractional basis. This role is ideal for a senior professional (Director or above) with deep operational, GCP, and vendor oversight experience who thrives in fast-paced, resource-constrained environments.
Responsibilities
- Provide senior-level clinical operations leadership across oncology trials, supporting protocol development, feasibility assessments, and operational strategy.
- Serve as a strategic advisor to the CEO by proactively identifying potential risks to the clinical trial and implementing effective mitigation strategies to ensure trial continuity and success.
- Travel to U.S. clinical sites for qualification, initiation, monitoring, QC, and close-out visits.
- Partner with the leadership team in CRO and specialty vendor vetting and selection, including contributions to the RFP process, proposal reviews, and operational due diligence.
- Support negotiation of scope, timelines, and deliverables with selected vendors.
- Play a key role, in collaboration with the acting CMO and Clinical Research Organization, on the development of a patient enrollment strategy.
- Monitor and report patient enrollment statistics to the leadership team. Proactively drive patient enrollment by identifying opportunities to increase enrollment and supporting site-level troubleshooting.
- Improve the quality, efficiency, and safety oversight of the study through the development and implementation of risk-based monitoring.
- Proactively monitor site compliance, resolve deviations, and implement corrective action plans to reduce protocol violations.
- Manage clinical data quality, ensuring timely and accurate data entry, query resolution, and alignment with EDC systems.
- Ensure GCP compliance and inspection readiness through documentation review, site training, and audit support.
- Report and monitor clinical trial budgets, forecast expenses, and track change orders in collaboration with finance.
- Partner cross-functionally with regulatory, biometrics, clinical science, and medical teams to ensure aligned trial execution.
- Use clinical systems (e.g., CTMS, EDC, eTMF, IRT/IWRS) to monitor site performance, document trial milestones, and track compliance.
- Support operational workflows involving next-generation sequencing (NGS) as a key patient selection criterion, including logistics, turnaround time tracking, and data reconciliation.
- Interface with central NGS screening laboratories to coordinate timely reporting of biomarker data for eligibility confirmation.
- Outline processes for integrating central labs (for biomarker testing) into the patient screening workflow, ensuring timely eligibility confirmation.
Required Qualifications
- 10+ years of experience in clinical operations, with demonstrated leadership in oncology trials.
- Previous experience with implementing risk-based monitoring programs.
- Ability to travel to clinical sites and experience building positive partnerships with CROs and clinical site personnel.
- Solid tumor experience is required; precision oncology and biomarker-driven trial experience strongly preferred.
- Proven success in reducing protocol violations and improving site enrollment performance.
- Strong track record (defined as on time, on budget and with minimal protocol deviations) with Phase 1b/2a and late-phase studies.
- Deep knowledge of Good Clinical Practice (GCP), ICH guidelines, and U.S. regulatory requirements.
- Experience conducting site qualification/initiation/close-out visits and active site monitoring and site remediation training if necessary.
- Demonstrated experience participating in CRO/vendor selection and RFP processes, including proposal evaluation and operational input.
- Proficient in clinical systems such as CTMS, EDC, eTMF, and IRT.
- Experience with budget development, site payments, and financial oversight.
- Willingness to travel domestically to clinical sites as needed.
- Experience coordinating with central labs to confirm biomarker eligibility for patient inclusion.
- Proven ability to successfully and effectively interface with world-class level clinical investigators and their study coordinators while representing the sponsor at the highest levels of ethical and professional conduct.
Preferred Qualifications
- Background in precision oncology, companion diagnostics, or targeted therapy trials. Deep operational experience with next-generation sequencing (NGS) in clinical trials, particularly in its use as a diagnostic and patient selection tool.
- Prior experience in FDA or EMA inspection preparation.
- Clinical development experience within small biotech or emerging oncology companies.
Seniority level
Employment type
Job function
- Research, Analyst, and Information Technology
Industries
- Biotechnology Research and Pharmaceutical Manufacturing